Correlation Between Regenxbio and Coya Therapeutics,
Can any of the company-specific risk be diversified away by investing in both Regenxbio and Coya Therapeutics, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Regenxbio and Coya Therapeutics, into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Regenxbio and Coya Therapeutics, Common, you can compare the effects of market volatilities on Regenxbio and Coya Therapeutics, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Regenxbio with a short position of Coya Therapeutics,. Check out your portfolio center. Please also check ongoing floating volatility patterns of Regenxbio and Coya Therapeutics,.
Diversification Opportunities for Regenxbio and Coya Therapeutics,
-0.3 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Regenxbio and Coya is -0.3. Overlapping area represents the amount of risk that can be diversified away by holding Regenxbio and Coya Therapeutics, Common in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Coya Therapeutics, Common and Regenxbio is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Regenxbio are associated (or correlated) with Coya Therapeutics,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Coya Therapeutics, Common has no effect on the direction of Regenxbio i.e., Regenxbio and Coya Therapeutics, go up and down completely randomly.
Pair Corralation between Regenxbio and Coya Therapeutics,
Given the investment horizon of 90 days Regenxbio is expected to under-perform the Coya Therapeutics,. But the stock apears to be less risky and, when comparing its historical volatility, Regenxbio is 1.21 times less risky than Coya Therapeutics,. The stock trades about -0.03 of its potential returns per unit of risk. The Coya Therapeutics, Common is currently generating about 0.04 of returns per unit of risk over similar time horizon. If you would invest 580.00 in Coya Therapeutics, Common on September 8, 2024 and sell it today you would earn a total of 32.00 from holding Coya Therapeutics, Common or generate 5.52% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
Regenxbio vs. Coya Therapeutics, Common
Performance |
Timeline |
Regenxbio |
Coya Therapeutics, Common |
Regenxbio and Coya Therapeutics, Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Regenxbio and Coya Therapeutics,
The main advantage of trading using opposite Regenxbio and Coya Therapeutics, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Regenxbio position performs unexpectedly, Coya Therapeutics, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Coya Therapeutics, will offset losses from the drop in Coya Therapeutics,'s long position.Regenxbio vs. Day One Biopharmaceuticals | Regenxbio vs. Replimune Group | Regenxbio vs. Mirum Pharmaceuticals | Regenxbio vs. Rocket Pharmaceuticals |
Coya Therapeutics, vs. Cue Biopharma | Coya Therapeutics, vs. Lantern Pharma | Coya Therapeutics, vs. Fennec Pharmaceuticals | Coya Therapeutics, vs. Eliem Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.
Other Complementary Tools
Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences |